Discontinuation of Direct Oral Anticoagulants in Response to Attorney Advertisements: Data From the FDA Adverse Event Reporting System.

Discontinuation of Direct Oral Anticoagulants in Response to Attorney Advertisements: Data From the FDA Adverse Event Reporting System. Ann Pharmacother. 2019 May 05;:1060028019849664 Authors: Mohamoud M, Patanavanich S, Crew P, McCulley L, Munoz M, Kortepeter C, Jones SC, Woronow D, Dal Pan G PMID: 31055957 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31055957?dopt=Abstract

Source: The Annals of Pharmacotherapy - May 4, 2019 Category: Drugs & Pharmacology Authors: Mohamoud M, Patanavanich S, Crew P, McCulley L, Munoz M, Kortepeter C, Jones SC, Woronow D, Dal Pan G Tags: Ann Pharmacother Source Type: research

More News: Advertising | Drugs & Pharmacology